C9200 | AML1/ETO | AML1/ETO |
|
C9201 | ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´, inv(16)(p13:q22) | Acute myeloid leukaemia, inv(16)(p13:q22) |
|
C9201 | ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´, t(16:16)(p13:q11) | Acute myeloid leukaemia, t(16:16)(p13:q11) |
|
C9201 | ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´, CBF-beta/MYH11 | Acute myeloid leukaemia, CBF-beta/MYH11 |
|
C9208 | ±âŸ ¹× »ó¼¼ºÒ¸íÀÇ ±Þ¼º °ñ¼ö¸ð¼¼Æ÷¼º ¹éÇ÷º´[AML] | Other and inspecigied acute myeloblastic leukaemia [AML] |
|
C9208 | ±Þ¼º °ñ¼ö¸ð¼¼Æ÷¼º ¹éÇ÷º´, ÃÖ¼ÒºÐÈ | Acute myeloblastic leukaemia, minimal differentiation |
|
C9208 | ±Þ¼º °ñ¼ö¸ð¼¼Æ÷¼º ¹éÇ÷º´(¼º¼÷À» µ¿¹ÝÇÑ) | Acute myeloblastic leukaemia (with maturation) |
|
C9208 | ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ M0 | AML M0 |
|
C9208 | ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ M1 | AML M1 |
|
C9208 | ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ M2 | AML M2 |
|
C9208 | ±Þ¼º °ñ¼ö¼º ¹éÇ÷º´ (FABºÐ·ù¸¦ µ¿¹ÝÇÏÁö ¾ÊÀº) NOS | AML (without FAB) NOS |
|
C9208 | º¯ÇüµÈ ¸ð¼¼Æ÷°úÀ×À» µ¿¹ÝÇÑ ºÒÀÀ¼ººóÇ÷ | Refractory anaemia with excess blasts in transformation |
|
C921 | ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´[CML], BCR/ABL-¾ç¼º | Chronic myeloid leukemia[CML],BCR/ABL-positive |
|
C921 | ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´, Çʶóµ¨ÇÇ¾Æ ¿°»öü ¾ç¼º | Chronic myelogenous leukemia, Philadelphia chromosome (Ph1) positive |
|
C921 | ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´, t(9:22)(q34:q11) | Chronic myelogenous leukemia, t(9:22)(q34:q11) |
|
C921 | ¸ð¼¼Æ÷ÀÇ ¹ßÁõÀ» µ¿¹ÝÇÑ ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´ | Chronic myelogenous leukemia with crisis of blast cells |
|
C922 | ºñÁ¤ÇüÀû ¸¸¼º °ñ¼ö¼º ¹éÇ÷º´[CML], BCR/ABL À½¼º | Atypical chronic myeloid leukemia[CML], BCR/ABL-negative |
|
C923 | °ñ¼ö¼º À°Á¾ | Myeloid sarcoma |
|
C923 | ³ì»öÁ¾ | Chloroma |
|
C923 | °ú¸³±¸¼º À°Á¾ | Granulocytic sarcoma |
|